You are leaving this ANI Pharmaceuticals website. This link will take you to a website to which our Online Privacy Policy does not apply. You are solely responsible for your interactions with that website.
 |
||||||
 |
 |
 |
 |
|||
 |
 |
|
 |
|
|
LITHOBID (lithium carbonate) is an extended-release formulation containing 300mg of lithium carbonate. LITHOBID is indicated in the treatment of manic episodes of Bipolar Disorder. Bipolar Disorder, Manic (DSM-IV) is equivalent to Manic Depressive illness, Manic, in the older DSM-II terminology. LITHOBID is also indicated as a maintenance treatment for individuals with a diagnosis of Bipolar Disorder. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes that may occur. |
|
||||
 |
|
||||
 |
|
||||
|
|
||||